Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$261M |
| 2 |
Alibaba
BABA
|
+$233M |
| 3 |
Truist Financial
TFC
|
+$191M |
| 4 |
Microsoft
MSFT
|
+$160M |
| 5 |
Amazon
AMZN
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$415M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$186M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$73.8M |
| 4 |
Oracle
ORCL
|
+$25.8M |
| 5 |
CBLK
Carbon Black, Inc. Common Stock
CBLK
|
+$23.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Financials | 15.12% |
| 3 | Healthcare | 12.68% |
| 4 | Consumer Discretionary | 10.28% |
| 5 | Communication Services | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Vera Bradley
VRA
$99.2M
| $708K | ﹤0.01% |
60,006
+2,938
| +5% | +$32.6K |
|
2152
Allogene Therapeutics
ALLO
$673M
| $706K | ﹤0.01% |
27,176
+7,729
| +40% | +$213K |
|
|
ARQL
2153
DELISTED
Arqule Inc
ARQL
| $704K | ﹤0.01% |
35,266
+13,512
| +62% | +$157K |
|
2154
Magnolia Oil & Gas
MGY
$5.62B
| $701K | ﹤0.01% |
55,696
+3,594
| +7% | +$40.3K |
|
|
LL
2155
DELISTED
LL Flooring Holdings, Inc.
LL
| $700K | ﹤0.01% |
71,555
+4,032
| +6% | +$37.7K |
|
2156
BancFirst
BANF
$3.83B
| $694K | ﹤0.01% |
11,127
+3,238
| +41% | +$191K |
|
|
RRD
2157
DELISTED
RR Donnelley & Sons Co.
RRD
| $693K | ﹤0.01% |
179,665
+9,392
| +6% | +$37.1K |
|
2158
Yeti Holdings
YETI
$3.98B
| $689K | ﹤0.01% |
19,807
+4,123
| +26% | +$130K |
|
|
TERP
2159
DELISTED
TerraForm Power, Inc
TERP
| $682K | ﹤0.01% |
44,309
+3,464
| +8% | +$55.8K |
|
2160
GrafTech
EAF
$200M
| $681K | ﹤0.01% |
5,861
| – | – |
|
|
RDUS
2161
DELISTED
Radius Health, Inc.
RDUS
| $681K | ﹤0.01% |
33,785
+1,805
| +6% | +$43.8K |
|
|
GHL
2162
DELISTED
Greenhill & Co., Inc.
GHL
| $668K | ﹤0.01% |
39,140
+220
| +0.6% | +$3.57K |
|
2163
Grocery Outlet
GO
$975M
| $656K | ﹤0.01% |
20,211
+19,466
| +2,613% | +$626K |
|
2164
James Hardie Industries
JHX
$16.5B
| $655K | ﹤0.01% |
33,312
+14,270
| +75% | +$265K |
|
|
ZUO
2165
DELISTED
Zuora, Inc.
ZUO
| $653K | ﹤0.01% |
45,571
+3,942
| +9% | +$57.8K |
|
|
CDR
2166
DELISTED
Cedar Realty Trust, Inc
CDR
| $651K | ﹤0.01% |
33,409
+1,177
| +4% | +$22.9K |
|
|
MAXR
2167
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $648K | ﹤0.01% |
41,329
-7,550
| -15% | -$78.4K |
|
2168
Theravance Biopharma
TBPH
$876M
| $646K | ﹤0.01% |
24,940
+1,762
| +8% | +$34.2K |
|
2169
CVR Energy
CVI
$3.14B
| $641K | ﹤0.01% |
15,869
+498
| +3% | +$21.9K |
|
2170
1st Source
SRCE
$2.17B
| $641K | ﹤0.01% |
12,356
+5,033
| +69% | +$253K |
|
2171
Cerence
CRNC
$424M
| $640K | ﹤0.01% |
+28,289
| New | +$464K |
|
2172
OR Royalties Inc
OR
$6.04B
| $639K | ﹤0.01% |
65,709
+22,200
| +51% | +$203K |
|
2173
Acushnet Holdings
GOLF
$6.04B
| $636K | ﹤0.01% |
19,583
| – | – |
|
|
KNL
2174
DELISTED
Knoll, Inc.
KNL
| $636K | ﹤0.01% |
25,184
+1,777
| +8% | +$47K |
|
|
BOLD
2175
DELISTED
Audentes Therapeutics, Inc
BOLD
| $633K | ﹤0.01% |
10,579
+1,757
| +20% | +$65.9K |
|
Similar funds
Legal & General Group's Q4 2019 Portfolio in Review
As of Q4 2019, Legal & General Group held 3,425 positions worth $210B, up 11% from $190B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3.9%. Legal & General Group opened 77 new positions and exited 57, leaving the 3,425-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- Legal & General Group's largest Q4 2019 buy was iShares MSCI Emerging Markets ETF: 425,000 shares worth $19.1M.
- Legal & General Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $261M increase.
- Legal & General Group's biggest Q4 2019 reduction was Oracle, cutting an estimated $25.8M.
- Legal & General Group fully exited Celgene Corp in Q4 2019, selling an estimated $415M.
- Legal & General Group's ten largest holdings make up 18% of its $210B portfolio in Q4 2019.
- Legal & General Group opened 77 new positions and closed 57 in Q4 2019.
- Legal & General Group's portfolio value rose 11% quarter-over-quarter to $210B.
Based on Legal & General Group's 13F filing for Q4 2019, filed 13 Feb 2020.